Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
02/2014
02/18/2014CA2429814C Rna interference mediating small rna molecules
02/18/2014CA2331923C Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
02/13/2014WO2014026054A2 CD20 scFv-ELPs METHODS AND THERAPEUTICS
02/13/2014WO2014026053A1 Cd25 pre-selective combination anti-hiv vectors, targeting vectors, and methods of use
02/13/2014WO2014024820A1 Pharmaceutical composition for treating new chronic kidney disease and method for screening medicine for new chronic kidney disease
02/13/2014US20140045923 Gene therapy compositions for preventing and/or treating of autoimmune diseases
02/13/2014US20140045916 Splice-region antisense composition and method
02/13/2014US20140044737 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
02/13/2014US20140044684 Methods And Compositions For Regulating Gene Expression
02/12/2014EP2694660A1 Efficient protein expression in vivo using modified rna (mod-rna)
02/12/2014EP2694114A1 A skeletal muscle-specific enhancer
02/12/2014CN103571927A Applications of human SAMD9L gene and protein product encoded by human SAMD9L gene
02/12/2014CN103571848A Virulence gene of punctate palmoplantar keratodermas and use thereof
02/12/2014CN103571845A Aptamer for inhibiting mast cell calcium channel and preparation method thereof
02/12/2014CN103571843A Nano-particle wrapped with small RNA (Ribose Nucleic Acid) for inhibiting embryo implantation
02/12/2014CN103571836A Efficient antibacterial activity antisense nucleic acid sequence of multidrug resistant Acinetobacter baumannii
02/12/2014CN103570942A Polyethyleneimine function cation polymer derived from natural cholesterol, synthesis method and uses thereof
02/12/2014CN103570821A Mucin-1 antigenic polypeptide and application thereof as tumor vaccine
02/12/2014CN103570818A Tumor antigenic polypeptide and application thereof as tumor vaccine
02/12/2014CN103566379A Preparation and application of intracellular triggering reduction sensitive drug linked gene targeted co-carrier
02/12/2014CN103566378A Tumor nucleic acid vaccine based on tissue factor as well as preparation method and application of vaccine
02/12/2014CN103566374A Polyethyleneimine lipid composite nano-carrier and preparation method thereof, and polyethyleneimine lipid composite nanometer gene drug
02/12/2014CN103565744A Macromolecular phosphatidylglycerol nanoliposome, and preparation methods and applications thereof
02/12/2014CN102453757B Application of micro RNA and antisense nucleic acid thereof in diagnosis, prevention, treatment and/or prognosis evaluation of myocardial ischemic injury
02/12/2014CN102304515B RNA interference sequence aiming at hepatocyte nuclear factor 4a and applications thereof
02/12/2014CN101704892B Anti-uPAR humanized antibody, coding gene and application thereof
02/12/2014CN101448944B Treatment of CNS conditions
02/11/2014USRE44760 Antisense modulation of apolipoprotein B-expression
02/11/2014US8648186 Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
02/11/2014US8648185 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
02/11/2014US8648174 Ucp4
02/11/2014US8648171 Members of the FC receptor homolog gene family (FcRH1-3,6) related reagents and uses thereof
02/11/2014US8648053 Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for Usher syndrome
02/11/2014US8648051 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
02/11/2014US8647864 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
02/11/2014US8647863 Minicircle vector production
02/11/2014US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
02/11/2014US8647820 Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription
02/11/2014US8647629 Powerful MHC-class II peptides derived from survivin
02/11/2014CA2549930C Cd34+ stem cells
02/11/2014CA2524255C Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
02/11/2014CA2498502C Recombinant clostridial toxin fragments with proteolytic activation
02/11/2014CA2471432C Nonhuman model animal lacking the ability to control lymphocyte migration
02/11/2014CA2461007C Use of cardiotrophin in liver diseases
02/11/2014CA2388045C Nucleic acid immunogenic compositions encoding hsp-antigen chimera
02/11/2014CA2387184C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
02/11/2014CA2357986C Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
02/06/2014WO2014022720A1 Polymer conjugates for delivery of biologically active agents
02/06/2014WO2014022702A2 Methods and compositions for controlling gene expression by rna processing
02/06/2014WO2014022582A1 Intrathecal delivery of recombinant adeno-associated virus 9
02/06/2014WO2014022332A1 Modulation of the immune response
02/06/2014WO2014022185A2 Method to treat or prevent herpesvirus infections
02/06/2014WO2014022138A2 Live and in-vivo tumor specific cancer vaccine system developed by co-administration of either at least two or all three of the following components such as tumor cells, an oncolytic virus vector with transgenic expression of gm-csf and an immune checkpoint modulator
02/06/2014WO2014021683A1 Composition for promoting hair growth
02/06/2014WO2014021678A1 Microbubble-nanoliposome complex for cancer diagnosis and treatment
02/06/2014WO2014021667A1 Composition for treating cancer associated with hpv infection
02/06/2014WO2014020184A1 Means for treating heart disease
02/06/2014WO2014019025A1 Epcam aptamer for detection of cancer stem cells
02/06/2014WO2014019024A1 Cd133 aptamers for detection of cancer stem cells
02/06/2014US20140037635 Methods of treatment using il-17e antagonists
02/06/2014US20140037585 AAV8 Vector with Enhanced Functional Activity and Methods of Use Thereof
02/06/2014US20140037545 Inhibition of fibrosis and af by tgf-beta inhibition in the posterior left atrium (pla)
02/05/2014EP2692731A1 Recombinant Adeno-Associated virus (AAV) vector particles displaying high-affinity ligands for cell-type specific gene delivery
02/05/2014EP2692354A1 Means for treating heart disease
02/05/2014EP2691121A2 Compositions and methods for inhibiting expression of tmprss6 gene
02/05/2014EP2691120A2 Theranostic imaging agents and methods of use
02/05/2014CN103562386A REIC-expressing adenovirus vector
02/05/2014CN103561775A Liposome containing shRNA molecule for thymidylate synthase, and use for same
02/05/2014CN103561774A Adeno-associated virus virions with variant capsid and methods of use thereof
02/05/2014CN103561773A Theranostic imaging agents and methods of use
02/05/2014CN103561761A Methods and compositions for improving antiangiogenic therapy with anti-integrins
02/05/2014CN103561725A Vector for pulmonary delivery, inducing agent, and uses
02/05/2014CN103555767A Preparation method and applications of microRNA nano-carrier self-assembled layer by layer
02/05/2014CN103555765A Transcriptional regulation tumor targeting replicative oncolytic adenovirus vector, oncolytic adenovirus carrying therapy gene and preparation method and application thereof
02/05/2014CN103555764A MUC1 (Mucins) and IL-2 double-gene coexpression recombinant vector as well as preparation method and application thereof
02/05/2014CN103555763A IL-2 and MART-1 dual-gene co-expression recombinant vector as well as preparation method and application of recombinant vector
02/05/2014CN103555762A AFP and GM-CSF dual-gene co-expression recombinant vector as well as preparation method and application of recombinant vector
02/05/2014CN103555747A Gliocyte bFGF expression enhancement system, as well as construction method and application thereof
02/05/2014CN103555746A Recombinant porcine circovirus type 2 virus-like particle, and preparation method and application thereof
02/05/2014CN103555731A Ser536 phosphorylated gene of NF-kB RelA/p65 and use thereof
02/05/2014CN103555730A Large yellow croaker tropomyosin gene as well as recombinant protein and application thereof
02/05/2014CN103555722A Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
02/05/2014CN103555678A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
02/05/2014CN103555677A A method of identifying unknown adeno-associated virus (avv) sequences and a kit for the metho
02/05/2014CN103555676A A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
02/05/2014CN103554241A Recombinant protein ASPPR with immunoregulatory activity and application thereof
02/05/2014CN103554205A Compounds and methods for modulating expression of gccr
02/05/2014CN103550789A Preparation and application of oral tumor vaccine with attenuated salmonella typhimurium as vector
02/05/2014CN103550788A Health-care method for improving immune effect of livestock and poultry vaccine and reducing immunological stress
02/05/2014CN103550787A MicroRNA (ribonucleic acid) antagonist and application thereof
02/05/2014CN103550786A Supermolecular nano-assembly for gene therapy and preparation method thereof
02/05/2014CN103550785A Novel use of TGF (Transforming Growth Facto)-beta receptor binding protein-1
02/05/2014CN103550784A Disease prevention and relief through human myoblast transplantation
02/05/2014CN103550783A Nucleic acid drug targeting delivery system and preparation method thereof
02/05/2014CN103550764A Novel method and compositions
02/05/2014CN102911940B Small ribonucleic acid interference molecule for specifically inhibiting NK (Natural Killer) cell receptor KIR3DL1 and application of small ribonucleic acid interference molecule
02/05/2014CN102675424B Polypeptide drug for resisting Hepatitis B virus X protein
02/05/2014CN102675423B Polypeptide medicine against hepatitis B virus X protein
02/05/2014CN102675422B Polypeptide drug against hepatitis B virus X protein (HBx)
02/05/2014CN102206663B Nucleic acid construct containing full-length genome of human hepatitis C virus and uses
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 870